Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis

G. H. McCracken, M. A. Sande, A. Lentnek, R. J. Whitley, W. M. Scheld

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Predisposing conditions for acute bacterial meningitis include prematurity, young age, management in an intensive care setting, low socioeconomic background, and crowded living conditions. Clinical findings vary with age and may be nonspecific (altered feeding behavior) or specific (Kernig and Brudzinski signs). Examination and culture of cerebrospinal fluid (CSF) are essential for diagnosis. Antigen identification in CSF, serum, or urine by latex agglutination or other techniques can be useful in the identification of the pathogen. Randomized, controlled studies with a single- , double-, or evaluator-blinded design are encouraged. Among neonates, infants, and children, CSF should be examined again 24-36 hours after initiation of therapy. Outcomes should be judged by both clinical and microbiological criteria. Assessment of microbiological outcome is paramount.

Original languageEnglish (US)
JournalClinical Infectious Diseases
Volume15
Issue numberSUPPL. 1
StatePublished - 1992

Fingerprint

Bacterial Meningitides
Cerebrospinal Fluid
Pharmaceutical Preparations
Social Conditions
Agglutination
Latex
Feeding Behavior
Critical Care
Therapeutics
Outcome Assessment (Health Care)
Urine
Newborn Infant
Antigens
Serum

ASJC Scopus subject areas

  • Immunology

Cite this

McCracken, G. H., Sande, M. A., Lentnek, A., Whitley, R. J., & Scheld, W. M. (1992). Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis. Clinical Infectious Diseases, 15(SUPPL. 1).

Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis. / McCracken, G. H.; Sande, M. A.; Lentnek, A.; Whitley, R. J.; Scheld, W. M.

In: Clinical Infectious Diseases, Vol. 15, No. SUPPL. 1, 1992.

Research output: Contribution to journalArticle

McCracken, G. H. ; Sande, M. A. ; Lentnek, A. ; Whitley, R. J. ; Scheld, W. M. / Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis. In: Clinical Infectious Diseases. 1992 ; Vol. 15, No. SUPPL. 1.
@article{8b32e6c819b84454b9e2868e0432f8d3,
title = "Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis",
abstract = "Predisposing conditions for acute bacterial meningitis include prematurity, young age, management in an intensive care setting, low socioeconomic background, and crowded living conditions. Clinical findings vary with age and may be nonspecific (altered feeding behavior) or specific (Kernig and Brudzinski signs). Examination and culture of cerebrospinal fluid (CSF) are essential for diagnosis. Antigen identification in CSF, serum, or urine by latex agglutination or other techniques can be useful in the identification of the pathogen. Randomized, controlled studies with a single- , double-, or evaluator-blinded design are encouraged. Among neonates, infants, and children, CSF should be examined again 24-36 hours after initiation of therapy. Outcomes should be judged by both clinical and microbiological criteria. Assessment of microbiological outcome is paramount.",
author = "McCracken, {G. H.} and Sande, {M. A.} and A. Lentnek and Whitley, {R. J.} and Scheld, {W. M.}",
year = "1992",
language = "English (US)",
volume = "15",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis

AU - McCracken, G. H.

AU - Sande, M. A.

AU - Lentnek, A.

AU - Whitley, R. J.

AU - Scheld, W. M.

PY - 1992

Y1 - 1992

N2 - Predisposing conditions for acute bacterial meningitis include prematurity, young age, management in an intensive care setting, low socioeconomic background, and crowded living conditions. Clinical findings vary with age and may be nonspecific (altered feeding behavior) or specific (Kernig and Brudzinski signs). Examination and culture of cerebrospinal fluid (CSF) are essential for diagnosis. Antigen identification in CSF, serum, or urine by latex agglutination or other techniques can be useful in the identification of the pathogen. Randomized, controlled studies with a single- , double-, or evaluator-blinded design are encouraged. Among neonates, infants, and children, CSF should be examined again 24-36 hours after initiation of therapy. Outcomes should be judged by both clinical and microbiological criteria. Assessment of microbiological outcome is paramount.

AB - Predisposing conditions for acute bacterial meningitis include prematurity, young age, management in an intensive care setting, low socioeconomic background, and crowded living conditions. Clinical findings vary with age and may be nonspecific (altered feeding behavior) or specific (Kernig and Brudzinski signs). Examination and culture of cerebrospinal fluid (CSF) are essential for diagnosis. Antigen identification in CSF, serum, or urine by latex agglutination or other techniques can be useful in the identification of the pathogen. Randomized, controlled studies with a single- , double-, or evaluator-blinded design are encouraged. Among neonates, infants, and children, CSF should be examined again 24-36 hours after initiation of therapy. Outcomes should be judged by both clinical and microbiological criteria. Assessment of microbiological outcome is paramount.

UR - http://www.scopus.com/inward/record.url?scp=0026480260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026480260&partnerID=8YFLogxK

M3 - Article

VL - 15

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - SUPPL. 1

ER -